A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 38
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : TNS
Long Form : Total Neuropathy Score
No. Year Title Co-occurring Abbreviation
2020 A Comparative Study on the Diagnostic Utility of Corneal Confocal Microscopy and Tear Neuromediator Levels in Diabetic Peripheral Neuropathy. AUCs, CGRP, DPN
2020 A Randomized, Placebo-Controlled Trial Evaluating Changes in Peripheral Neuropathy and Quality of Life by Using Low-Frequency Electrostimulation on Breast Cancer Patients Treated With Chemotherapy. CIPN, CIPN20, ES, FACT-B, IPIE-CIPN, NRS, SES
2020 Association of corneal nerve loss with markers of axonal ion channel dysfunction in type 1 diabetes. CCM, CNFD, DPN, IWL
2020 Corneal nerve fiber loss in diabetes with chronic kidney disease. CKD
2020 Safety and tolerability of cryocompression as a method of enhanced limb hypothermia to reduce taxane-induced peripheral neuropathy. NCS
2019 Randomised controlled trial of the impact of haemodiafiltration on uraemic neuropathy: FINESSE study protocol. FINESSE, HD, HDF
2019 Tear film substance P: A potential biomarker for diabetic peripheral neuropathy. CGRP, DPN, SP
2018 Rechallenge with oxaliplatin and peripheral neuropathy in colorectal cancer patients. CRC, NCI, OIN, OXA
2018 The utility of the Total Neuropathy Score as an instrument to assess neuropathy severity in chronic kidney disease: A validation study. CKD, CKD
10  2017 A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN). CIPN, EORTC, PNQ
11  2017 Chemotherapy-Induced Peripheral Neuropathy Assessment Tools: A Systematic Review CIPN
12  2017 Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy. NCI-CTC, OSNS
13  2017 Haemodialysis alters peripheral nerve morphology in end-stage kidney disease. CSA, ESKD, HF, US
14  2016 Symptomatic and Electrodiagnostic Features of Peripheral Neuropathy in Scleroderma. NCS
15  2015 Intravenous glutamine appears to reduce the severity of symptomatic platinum-induced neuropathy: a prospective randomized study. ---
16  2015 Late effects of oxaliplatin-induced peripheral neuropathy (LEON)--cross-sectional cohort study of patients with colorectal cancer surviving at least 2 years. LEON, QOL
17  2015 Optimizing measures of HIV-associated neuropathy. CASS, DSP, M-CASS, QST
18  2013 Autonomic dysfunction is common in HIV and associated with distal symmetric polyneuropathy. CASS, DSP
19  2012 Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes. NCS
20  2011 Quality of life and objective measures of diabetic neuropathy in a prospective placebo-controlled trial of ruboxistaurin and topiramate. IENFD, NIS, NSS, NTSS-6, RBX
21  2010 Association of self-reported painful symptoms with clinical and neurophysiologic signs in HIV-associated sensory neuropathy. CHARTER, DNPP
22  2010 Measures of chemotherapy-induced peripheral neuropathy: a systematic review of psychometric properties. CIPN, QOL, QUADAS
23  2010 Vitamin E neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trial. ---
24  2008 Peripheral neuropathy due to paclitaxel: study of the temporal relationships between the therapeutic schedule and the clinical quantitative score (QST) and comparison with neurophysiological findings. PN, QST
25  2008 The total neuropathy score: a tool for measuring chemotherapy-induced peripheral neuropathy. CIPN
26  2007 Correlates of epidermal nerve fiber densities in HIV-associated distal sensory polyneuropathy. ART, DL, DSP, ENFD, GPS, HIV-DSP, PT, QST, SNAP, VAS
27  2007 Incidence and characteristics of peripheral neuropathy during oxaliplatin-based chemotherapy for metastatic colon cancer. OXLIPN
28  2007 The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale. CIPN, NCI-CTC
29  2006 HIV neuropathy natural history cohort study: assessment measures and risk factors. DSP, HIV, PN, QST
30  2006 Multi-center assessment of the Total Neuropathy Score for chemotherapy-induced peripheral neurotoxicity. CIPN, ECOG, NCI-CTC
31  2006 Pain affects the quality of life of neuropathic patients. QOL
32  2005 Clinical validation of the NeuroScreen. BNCS, BPNS, CI, DSPN, HIV, NP, PPV, ROC
33  2005 Reliability and validity of the CMT neuropathy score as a measure of disability. CMT, NIS
34  2005 Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine. ALC
35  2004 Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy. CIPN, NGF
36  2004 Peripheral neuropathy in Behcet's disease. BD
37  2003 Toxic neuropathy in patients with pre-existing neuropathy. ---
38  1999 Total neuropathy score: validation and reliability study. NIS, NSS